Published in Trends Cardiovasc Med on October 16, 2014
Optogenetics-enabled assessment of viral gene and cell therapy for restoration of cardiac excitability. Sci Rep (2015) 0.81
Computational modeling of cardiac optogenetics: Methodology overview & review of findings from simulations. Comput Biol Med (2015) 0.79
Anion channelrhodopsins for inhibitory cardiac optogenetics. Sci Rep (2016) 0.78
Optogenetic cardiac pacemakers: science or fiction? Trends Cardiovasc Med (2014) 0.76
Ultrasound modulates ion channel currents. Sci Rep (2016) 0.75
Light-based Approaches to Cardiac Arrhythmia Research: From Basic Science to Translational Applications. Clin Med Insights Cardiol (2016) 0.75
Cardiac optogenetics: using light to monitor cardiac physiology. Basic Res Cardiol (2017) 0.75
Millisecond-timescale, genetically targeted optical control of neural activity. Nat Neurosci (2005) 28.08
Channelrhodopsin-2, a directly light-gated cation-selective membrane channel. Proc Natl Acad Sci U S A (2003) 15.17
Electrical stimulation of excitable tissue: design of efficacious and safe protocols. J Neurosci Methods (2005) 6.30
Channelrhodopsin-2 and optical control of excitable cells. Nat Methods (2006) 5.46
Injectable, cellular-scale optoelectronics with applications for wireless optogenetics. Science (2013) 4.50
Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts. Nature (2014) 4.00
Independent optical excitation of distinct neural populations. Nat Methods (2014) 3.53
ReaChR: a red-shifted variant of channelrhodopsin enables deep transcranial optogenetic excitation. Nat Neurosci (2013) 2.98
Spectral characteristics of the photocycle of channelrhodopsin-2 and its implication for channel function. J Mol Biol (2007) 2.88
Optogenetic control of cardiac function. Science (2010) 2.63
Optogenetic control of heart muscle in vitro and in vivo. Nat Methods (2010) 2.47
Intracoronary cardiosphere-derived cells after myocardial infarction: evidence of therapeutic regeneration in the final 1-year results of the CADUCEUS trial (CArdiosphere-Derived aUtologous stem CElls to reverse ventricUlar dySfunction). J Am Coll Cardiol (2013) 2.34
Visualizing excitation waves inside cardiac muscle using transillumination. Biophys J (2001) 2.25
Waterproof AlInGaP optoelectronics on stretchable substrates with applications in biomedicine and robotics. Nat Mater (2010) 2.20
Stimulating cardiac muscle by light: cardiac optogenetics by cell delivery. Circ Arrhythm Electrophysiol (2011) 2.18
Finding fluorescent needles in the cardiac haystack: tracking human mesenchymal stem cells labeled with quantum dots for quantitative in vivo three-dimensional fluorescence analysis. Stem Cells (2007) 1.84
Photocycles of channelrhodopsin-2. Photochem Photobiol (2009) 1.76
Robust cardiomyocyte-specific gene expression following systemic injection of AAV: in vivo gene delivery follows a Poisson distribution. Gene Ther (2010) 1.58
3D multifunctional integumentary membranes for spatiotemporal cardiac measurements and stimulation across the entire epicardium. Nat Commun (2014) 1.52
Synthesis of voltage-sensitive optical signals: application to panoramic optical mapping. Biophys J (2006) 1.48
Gene therapy for heart failure. Circ Res (2012) 1.46
Multiscale computational models for optogenetic control of cardiac function. Biophys J (2011) 1.34
Toward the second generation of optogenetic tools. J Neurosci (2010) 1.33
Optogenetics and translational medicine. Sci Transl Med (2013) 1.31
A comprehensive multiscale framework for simulating optogenetics in the heart. Nat Commun (2013) 1.27
Computational optogenetics: empirically-derived voltage- and light-sensitive channelrhodopsin-2 model. PLoS Comput Biol (2013) 1.25
Targeted modification of atrial electrophysiology by homogeneous transmural atrial gene transfer. Circulation (2005) 1.24
Cardiac optogenetics. Am J Physiol Heart Circ Physiol (2013) 1.24
Optical mapping of optogenetically shaped cardiac action potentials. Sci Rep (2014) 1.16
Stem cell engraftment and survival in the ischemic heart. Ann Thorac Surg (2011) 1.09
Modulation of cardiac tissue electrophysiological properties with light-sensitive proteins. Cardiovasc Res (2014) 1.05
Light-induced termination of spiral wave arrhythmias by optogenetic engineering of atrial cardiomyocytes. Cardiovasc Res (2014) 0.98
Ventricular resynchronization therapy by direct His-bundle pacing using an internal cardioverter defibrillator. Europace (2012) 0.96
Long-term channelrhodopsin-2 (ChR2) expression can induce abnormal axonal morphology and targeting in cerebral cortex. Front Neural Circuits (2013) 0.95
Optogenetic manipulation of cerebellar Purkinje cell activity in vivo. PLoS One (2011) 0.95
Advances in modeling ventricular arrhythmias: from mechanisms to the clinic. Wiley Interdiscip Rev Syst Biol Med (2013) 0.91
Optogenetics-enabled dynamic modulation of action potential duration in atrial tissue: feasibility of a novel therapeutic approach. Europace (2014) 0.88
Optogenetic activation of Gq signalling modulates pacemaker activity of cardiomyocytes. Cardiovasc Res (2014) 0.88
Simulating photon scattering effects in structurally detailed ventricular models using a Monte Carlo approach. Front Physiol (2014) 0.85
Channelrhodopsin2 current during the action potential: "optical AP clamp" and approximation. Sci Rep (2014) 0.84
Defibrillation efficacy and pain perception of two biphasic waveforms for internal cardioversion of atrial fibrillation. J Cardiovasc Electrophysiol (2003) 0.84
See the light: can optogenetics restore healthy heartbeats? And, if it can, is it really worth the effort? Expert Rev Cardiovasc Ther (2013) 0.84
Comparison of ICD implantation in obese and nonobese patients. Pacing Clin Electrophysiol (2013) 0.79